Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-31

Clinical Trial Update: Chromium and Insulin Resistance [NA]

View source ↗

Summary

A clinical trial investigating chromium for insulin resistance has completed, according to UCSF as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chromium (Chromium)

Snippet

Sponsor: University of California, San Francisco | Conditions: Insulin Resistance | NA | Status: COMPLETED